Cheryl Willman, MD, CEO of UNM's Comprehensive Cancer Center, discusses next-generation treatments - focusing on the genetic make-up of cancer, customizing treatment and paving the way to greater success in recovery and remission.
Angela Wandinger-Ness, PhD, has been chosen to receive the 2019 STC.UNM Innovation Fellow Award in recognition of her achievements as a leading innovator at the University of New Mexico. "We couldn’t be more proud of her accomplishments; they will have an impact on ovarian cancer patients and on future scientists,” says Cheryl Willman, MD, UNM Comprehensive Cancer Center Director and CEO.
Support the UNM Cancer Center — Register for the Lobo Cancer Challenge
shadow
